Evidence map›Paper›PMID 20177734›Full record

ArticleJournal of industrial microbiology & biotechnology2010

Enantioselective hydrolysis of (R)-2, 2-dimethylcyclopropane carboxamide by immobilized cells of an R-amidase-producing bacterium, Delftia tsuruhatensis CCTCC M 205114, on an alginate capsule carrier.

Yuan-Shan Wang, Ren-Chao Zheng, Jian-Miao Xu, Zhi-Qiang Liu, Feng Cheng, Zhi-Hua Feng, Li-Ling Liu, Yu-Guo Zheng, Yin-Chu Shen

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuan-Shan WangInstitute of Bioengineering, Zhejiang University of Technology, 18 Chaowang Road, Hangzhou, People's Republic of China.
Ren-Chao Zheng
Jian-Miao Xu
Zhi-Qiang Liu
Feng Cheng
Zhi-Hua Feng
Li-Ling Liu
Yu-Guo Zheng
Yin-Chu Shen
Zhejiang University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immobilized cells of Delftia tsuruhatensis CCTCC M 205114 harboring R-amidase were applied in asymmetric hydrolysis of (R)-2, 2-dimethylcyclopropane carboxamide (R - 1) from racemic (R, S)-2, 2-dimethylcyclopropane carboxamide to accumulate (S)-2, 2-dimethylcyclopropane carboxamide (S - 1). Maximum R-amidase activity of 13.1 U/g wet cells (0.982 U/g beads) was obtained under conditions of 3% sodium alginate, 2.5% CaCl(2), 15 h crosslinking and 2 mm bead size, which was 53.9% of that of free cells (24.3 U/g wet cells). In addition, characterization of the immobilized cells was examined. The optimum R - 1 hydrolysis conditions were identified as follows: substrate concentration 10 mM, pH 8.5, temperature 35 degrees C and time course 40 min. Under optimum conditions, the maximum yield and enantiomeric excess of (R)-2, 2-dimethylcyclopropanecarboxylic acid were 49.5% and >99%, respectively. This afforded S - 1 with a yield >49% and an e.e. of 97.7%. With good operational stability and excellent enanotioselectivity, the immobilized cells could be potentially utilized in industrial production of S - 1.

Indexed as

Industrial MicrobiologyAlginatesAmidohydrolasesCells, ImmobilizedCyclopropanesDelftiaGlucuronic AcidHexuronic AcidsHydrogen-Ion ConcentrationHydrolysisKineticsSoil MicrobiologyStereoisomerismTemperature2,2-dimethylcyclopropanecarboxamideAlginatesamidaseAmidohydrolasesCyclopropanesGlucuronic AcidHexuronic Acids

Identifiers

PMID20177734
OpenAlexW2046295571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.